3-(Chloromethyl)-1,2,4-oxadiazole → HCID 66707329, compound
Reaction equation
C(OC([N:8]1[CH2:14][CH2:13][C:12]2[C:15]([S:20][C:21](=O)N(C)C)=[C:16]([Cl:19])[CH:17]=[CH:18][C:11]=2[CH2:10][CH2:9]1)=O)(C)(C)C.ClC[C:28]1[N:32]=[CH:31][O:30][N:29]=1>>[ClH:19].[Cl:19][C:16]1[CH:17]=[CH:18][C:11]2[CH2:10][CH2:9][NH:8][CH2:14][CH2:13][C:12]=2[C:15]=1[S:20][CH2:21][C:28]1[N:32]=[CH:31][O:30][N:29]=1Participants
3
Procedure
Use a method similar to the Preparation 177, using 3-tert-butoxycarbonyl-7-chloro-6-dimethylcarbamoylthio-2,3,4,5-tetrahydro-1H-benzo[d]azepine and 3-chloromethyl-1,2,4-oxadiazole to give, after deprotection using a method similar to the General Procedure 1-4, the title compound as a white solid. MS (ES+) m/z 296 (M+H)+.
Workup
- customsimilar to the Preparation 177
- customto give
Sources & evidence
- ORD record
- ord-521ae3aa358e4e74a03cec397fa15b28
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08022062B2
Reaction notes
Loading…